ZURICH (Thomson Financial) - Cosmo Pharmaceuticals SpA said it is preparing phase III trails for its treatment for infectious diarrhoea, Rifamycin SV MMX, after previous trails proved successful.
ZURICH (Thomson Financial) - Cosmo Pharmaceuticals SpA said it is preparing phase III trails for its treatment for infectious diarrhoea, Rifamycin SV MMX, after previous trails proved successful.